Nuklear Medicine

Welcome to the Department of Nuclear Medicine at the University Hospital (Universitätsklinikum Bonn, UKB)

The department of nuclear medicine of the University Hospital Bonn provide all diagnostic and therapeutic procedures using radiopharmaceuticals. Our department is one of the few institutions worldwide, which offers the complete spectrum of diagnosis and therapies using the newest methods. The methods in our feld is based predominantly on a specifc enrichment of different radiopharmaceuticals.

In this metabolic pathway, blood ﬂow and tumor-specifc accumulation mechanisms are utilized. This leads to a specifc radioactivity accumulation in the various organs, which is used for imaging.

Today, hybrid methods such as PET-CT and SPECT-CT play an important role. The results of the different imaging modalities are fused, so that the high spatial resolution of the CT is connected to the high-specifc resolution.

Prof. Dr. med. Markus Essler
Medical Director, Chair Department of Nuclear Medicine

Focus of treatment:

Diagnostic
Thyroid Outpatient Department
Positron Emission Tomography (PET)
Computer Tomography CT (PET/CT)
Lu-177-PSMA therapy for metastasized prostate cancer
Peptide receptor-mediated Radionuclide Therapy (PRRT) - neuroendocrine tumors
Selective Internal Radiotherapy (SIRT) - Radioembolisation. Treatment for liver tumors or metastases
Alpha-Therapy of bone metastases (Xofigo, Ra 223)
Radioimmunotherapy with Zevalin

Certificate TÜV-SÜD-English (PDF-Download)